Improved Long-Term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab

類似資料

• Proactive Infliximab Monitoring Following Reactive Testing is Associated With Better Clinical Outcomes Than Reactive Testing Alone in Patients With Inflammatory Bowel Disease
  著者:: Papamichael, Konstantinos, 等
  出版事項: (2018)
• Long-term outcome of infliximab optimization for overcoming immunogenicity in patients with inflammatory bowel disease
  著者:: Papamichael, Konstantinos, 等
  出版事項: (2018)
• Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn’s Disease: A Cost-Effectiveness Analysis in a Simulated Cohort
  著者:: Negoescu, Diana M, 等
  出版事項: (2020)
• Proactive Adalimumab Monitoring in Inflammatory Bowel Disease: Current Data and Future Perspectives
  著者:: Papamichael, Konstantinos, 等
  出版事項: (2020)
• Proactive Therapeutic Concentration Monitoring of Infliximab May Improve Outcomes for Patients with Inflammatory Bowel Disease: Results from a Pilot Observational Study
  著者:: Vaughn, Byron P., 等
  出版事項: (2014)